Author

Mariah Lofgren

National Institutes of HealthORCID 0000-0001-7453-3262Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 1 Assay:protein sequence· 1

Frequent Co-Authors

Azza H. IdrisiD· 2 shared Marlon DilloniD· 2 shared Robert A. SederiD· 2 shared Adian Valdez· 1 shared Alvaro Molina-CruziD· 1 shared Amy R. Henry· 1 shared Baoshan ZhangiD· 1 shared Brian G. BonillaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Azza H. IdrisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMay 7, 2026

Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challenge

Courtney E McDougal, Mark D. Langowski, Daria Nikolaeva…·Neil P. King

This study shows that nanoparticle vaccines with oligomannose glycans boost B cell responses and protection against malaria sporozoites compared to other glycan types.

1 citation

protein sequenceexperimental assay

𝕏 PostBluesky

Immunologynpj VaccinesPeer-reviewedApr 27, 2026

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21

Prabhanshu Tripathi, Ja‐Hyun Koo, Xuejun Chen…·Tongqing Zhou

This paper develops a nanoparticle-based junctional vaccine targeting PfCSP and compares its efficacy to the R21 vaccine in reducing malaria liver burden in mice.

2 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky